EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study

Nicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, Brandon Dionne, Ahmad Taqi, Abdalhamid Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T Anderson, Monica V Mahoney und 12 weitere

Infectious Diseases and Therapy · 2024-03 · 13 (3) · 565-579

DOI: 10.1007/s40121-024-00933-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infectious Diseases and Therapy, online erschienen am 01.03.2024. Verfasst von Nicholas Rebold und 23 weiteren Autor:innen. Beteiligte Einrichtung: Wayne State University, Detroit, MI, USA. nicholas.rebold@howard.edu. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

StaphylococcusStreptococcusBacteremiaBloodstream infectionDalbavancinGlycopeptidesInjection drug use

Autor:innen und Institutionen

  • Wayne State University, Detroit, MI, USA. nicholas.rebold@howard.edu.
  • Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI, 48201, USA. nicholas.rebold@howard.edu.
  • Department of Clinical and Administrative Pharmacy Sciences, College of Pharmacy, Howard University, 2300 4th St NW, Office 114, Washington, DC, 20059, USA. nicholas.rebold@howard.edu.
  • Wayne State University, Detroit, MI, USA.
  • Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI, 48201, USA.
  • Department of Pharmacy, Brigham and Women's Hospital, Boston, MA, USA.

Zitieren

APA

Rebold, N., Alosaimy, S., Pearson, J. C., Dionne, B., Taqi, A., Lagnf, A., Lucas, K., Biagi, M., Lombardo, N., Eudy, J., Anderson, D. T., Mahoney, M. V., Kufel, W. D., D'Antonio, J. A., Jones, B. M., Frens, J. J., Baumeister, T., Geriak, M., Sakoulas, G., …, & Rybak, M. J. (2024). Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study. Infectious Diseases and Therapy, 13(3), 565-579. https://doi.org/10.1007/s40121-024-00933-2

Vancouver

Rebold N, Alosaimy S, Pearson JC, Dionne B, Taqi A, Lagnf A, et al. Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study. Infectious Diseases and Therapy. 2024;13(3):565-579. doi:10.1007/s40121-024-00933-2

BibTeX
@article{Rebold2024,
  author = {Rebold, Nicholas and Alosaimy, Sara and Pearson, Jeffrey C and Dionne, Brandon and Taqi, Ahmad and Lagnf, Abdalhamid and Lucas, Kristen and Biagi, Mark and Lombardo, Nicholas and Eudy, Joshua and Anderson, Daniel T and Mahoney, Monica V and Kufel, Wesley D and D'Antonio, Joseph A and Jones, Bruce M and Frens, Jeremy J and Baumeister, Tyler and Geriak, Matthew and Sakoulas, George and Farmakiotis, Dimitrios and Delaportas, Dino and Larew, Jeremy and Veve, Michael P and Rybak, Michael J},
  title = {Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study},
  journal = {Infectious Diseases and Therapy},
  year = {2024},
  volume = {13},
  number = {3},
  pages = {565--579},
  doi = {10.1007/s40121-024-00933-2}
}
Kostenlos starten →